{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:45:10Z","timestamp":1770727510261,"version":"3.49.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The risk of hypertensive disorders of pregnancy (HDP) varies in women with gestational diabetes mellitus (GDM), depending on the degree of insulin resistance and is also influenced by obesity. The aim of this study was to evaluate clinical features, blood pressure (BP) profiles and inflammatory markers, to identify patients with an elevated risk of developing HDP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 146 normotensive pregnant women were studied. We analysed the relationships of BP profiles detected by ambulatory blood pressure monitoring (ABPM) with serum biomarkers and angiogenic factors and their association with the development of HDP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fourteen (9.6%) women developed HDP, of which 11 had GDM and 8 had obesity. Women with HDP had higher values of 24-h and daytime systolic\/diastolic BP (113\/69 vs. 104\/64; 115\/72 vs. 106\/66\u2009mmHg, respectively;<jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.05). Higher levels of leptin (10.97\u2009\u00b1\u20090.82 vs. 10.2\u2009\u00b1\u20091.11;<jats:italic>p<\/jats:italic>\u2009=\u20090.018) andmonocyte chemoattractant protein-1 (MCP-1) (5.24\u2009\u00b1\u20090.60 vs. 4.9\u2009\u00b1\u20090.55;<jats:italic>p<\/jats:italic>\u2009=\u20090.044) and a higher soluble fms-like tyrosine kinase-1\/placental growth factor (sFlt-1\/PlGF) ratio (4.37\u2009\u00b1\u20092.2 vs. 2.2\u2009\u00b1\u20091.43;<jats:italic>p<\/jats:italic>\u2009=\u20090.003) were also observed in the HDP patients. Multivariate analysis showed that a higher sFlt-1\/PlGF ratio was associated with an increased risk of developing HDP [OR\u2009=\u20092.02; IC 95%: 1.35\u20133.05]. Furthermore, higher daytime systolic BP [OR\u2009=\u20091.27; IC 95% 1.00\u20131.26] and prepregnancy body mass index (BMI) [OR\u2009=\u20091.14; IC 95%: 1.01\u20131.30] significantly increased the risk of developing HDP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Higher daytime systolic BP values, prepregnancy BMI and the sFlt-1\/PlGF ratio are useful for identifying normotensive pregnant women with an increased risk of developing HDP.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12958-022-01050-w","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:02:41Z","timestamp":1671775361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Higher daytime systolic BP, prepregnancy BMI and an elevated sFlt-1\/PlGF ratio predict the development of hypertension in normotensive pregnant women"],"prefix":"10.1186","volume":"20","author":[{"given":"Almudena","family":"Lara-Barea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"S\u00e1nchez-Lechuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Aguilar-Diosdado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"L\u00f3pez-Tinoco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"issue":"34","key":"1050_CR1","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstr\u00f6m-Lundqvist C, C\u00edfkov\u00e1 R, De Bonis M, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165\u2013241. https:\/\/doi.org\/10.1093\/eurheartj\/ehy340.","journal-title":"Eur Heart J"},{"issue":"4","key":"1050_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/dc11-1790","volume":"35","author":"PM Catalano","year":"2012","unstructured":"Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780\u20136. https:\/\/doi.org\/10.2337\/dc11-1790.","journal-title":"Diabetes Care"},{"issue":"12","key":"1050_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/1471-0528.12754","volume":"121","author":"H Fadl","year":"2014","unstructured":"Fadl H, Magnuson A, \u00d6stlund I, Montgomery S, Hanson U, Schwarcz E. Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study. BJOG An Int J Obstet Gynaecol. 2014;121(12):1530\u20136. https:\/\/doi.org\/10.1111\/1471-0528.12754.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"1050_CR4","doi-asserted-by":"publisher","unstructured":"Burlina S, Dalfr\u00e0 MG, Chilelli NC, Lapolla A. Gestational diabetes mellitus and future cardiovascular risk: an update. Int J Endocrinol. 2016;2016. https:\/\/doi.org\/10.1155\/2016\/2070926.","DOI":"10.1155\/2016\/2070926"},{"issue":"11","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1701-2163(15)30786-6","volume":"35","author":"KA Nerenberg","year":"2013","unstructured":"Nerenberg KA, Johnson JA, Leung B, Savu A, Ryan EA, Chik CL, et al. Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women. J Obstet Gynaecol Canada. 2013;35(11):986\u201394. https:\/\/doi.org\/10.1016\/S1701-2163(15)30786-6.","journal-title":"J Obstet Gynaecol Canada"},{"issue":"12","key":"1050_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/aje\/kwg273","volume":"158","author":"CL Bryson","year":"2003","unstructured":"Bryson CL, Ioannou GN, Rulyak SJ, Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension. Am J Epidemiol. 2003;158(12):1148\u201353. https:\/\/doi.org\/10.1093\/aje\/kwg273.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1050_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0178150","volume":"12","author":"J Lee","year":"2017","unstructured":"Lee J, Ouh YT, Ahn KH, Hong SC, Oh MJ, Kim HJ, et al. Preeclampsia: a risk factor for gestational diabetes mellitus in subsequent pregnancy. PLoS One. 2017;12(5):1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0178150.","journal-title":"PLoS One"},{"key":"1050_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.00655","volume":"11","author":"CJ McElwain","year":"2020","unstructured":"McElwain CJ, Tuboly E, McCarthy FP, McCarthy CM. Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future Cardiometabolic health? Front Endocrinol. 2020;11:1\u201319. https:\/\/doi.org\/10.3389\/fendo.2020.00655.","journal-title":"Front Endocrinol"},{"key":"1050_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3027363","volume":"2016","author":"C R\u01cedulescu","year":"2016","unstructured":"R\u01cedulescu C, Bac\u00e2rea A, Huanu A, Gabor R, Dobreanu M. Placental growth factor, soluble fms-like tyrosine kinase 1, soluble Endoglin, IL-6, and IL-16 as biomarkers in preeclampsia. Mediat Inflamm. 2016;2016:1\u20138. https:\/\/doi.org\/10.1155\/2016\/3027363.","journal-title":"Mediat Inflamm"},{"issue":"2","key":"1050_CR10","doi-asserted-by":"publisher","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","volume":"202","author":"S Verlohren","year":"2010","unstructured":"Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010;202(2):161.e1\u2013161.e11. https:\/\/doi.org\/10.1016\/j.ajog.2009.09.016.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1050_CR11","doi-asserted-by":"publisher","first-page":"13442","DOI":"10.3390\/ijms160613442","volume":"16","author":"SK Abell","year":"2015","unstructured":"Abell SK, De Courten B, Boyle JA, Teede HJ. Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. Int J Mol Sci. 2015;16(6):13442\u201373. https:\/\/doi.org\/10.3390\/ijms160613442.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2011.12.004","volume":"58","author":"C L\u00f3pez-Tinoco","year":"2012","unstructured":"L\u00f3pez-Tinoco C, Roca M, Fern\u00e1ndez-Deudero A, Garc\u00eda-Valero A, Bugatto F, Aguilar-Diosdado M, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine. 2012;58(1):14\u20139. https:\/\/doi.org\/10.1016\/j.cyto.2011.12.004.","journal-title":"Cytokine"},{"issue":"6","key":"1050_CR13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/jcm11061514","volume":"11","author":"A Lara-Barea","year":"2022","unstructured":"Lara-Barea A, S\u00e1nchez-Lechuga B, Campos-Caro A, C\u00f3rdoba-Do\u00f1a JA, de la Varga-Mart\u00ednez R, Arroba AI, et al. Angiogenic imbalance and inflammatory biomarkers in the prediction of hypertension as well as obstetric and perinatal complications in women with gestational diabetes mellitus. J Clin Med. 2022;11(6):1514. https:\/\/doi.org\/10.3390\/jcm11061514.","journal-title":"J Clin Med"},{"issue":"1","key":"1050_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/eci.12565","volume":"46","author":"M Gorostidi","year":"2016","unstructured":"Gorostidi M, Banegas JR, de la Sierra A, Vinyoles E, Segura J, Ruilope LM. Ambulatory blood pressure monitoring in daily clinical practice - the Spanish ABPM registry experience. Eur J Clin Investig. 2016;46(1):92\u20138. https:\/\/doi.org\/10.1111\/eci.12565.","journal-title":"Eur J Clin Investig"},{"key":"1050_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/10641955.2013.842585","volume":"33","author":"A Bhide","year":"2014","unstructured":"Bhide A, Sankaran S, Moore J, Khalil A, Furneaux E. Ambulatory blood pressure measurements in mid-pregnancy and development of hypertensive pregnancy disorders. Hypertens Pregnancy. 2014;33:159\u201367. https:\/\/doi.org\/10.3109\/10641955.2013.842585.","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/1573402114666180924143801","volume":"15","author":"AT Saremi","year":"2018","unstructured":"Saremi AT, Shafiee M-A, Montazeri M, Rashidi N, Montazeri M. Blunted overnight blood pressure dipping in second trimester; a strong predictor of gestational hypertension and preeclampsia. Curr Hypertens Rev. 2018;15(1):70\u20135. https:\/\/doi.org\/10.2174\/1573402114666180924143801.","journal-title":"Curr Hypertens Rev"},{"issue":"1","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/HJH.0000000000001848","volume":"37","author":"MR Salazar","year":"2019","unstructured":"Salazar MR, Espeche WG, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Balb\u00edn E, Stavile RN, et al. Nocturnal hypertension in high-risk mid-pregnancies predict the development of preeclampsia\/eclampsia. J Hypertens. 2019;37(1):182\u20136. https:\/\/doi.org\/10.1097\/HJH.0000000000001848.","journal-title":"J Hypertens"},{"issue":"5","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/jcm11051435","volume":"11","author":"A Lara-Barea","year":"2022","unstructured":"Lara-Barea A, S\u00e1nchez-Lechuga B, Vidal-Su\u00e1rez \u00c1, Arroba AI, Bugatto F, L\u00f3pez-Tinoco C. Blood pressure monitoring and perinatal outcomes in normotensive women with gestational diabetes mellitus. J Clin Med. 2022;11(5):1435. https:\/\/doi.org\/10.3390\/jcm11051435.","journal-title":"J Clin Med"},{"key":"1050_CR19","doi-asserted-by":"publisher","unstructured":"Nuzzo AM, Giuffrida D, Moretti L, Re P, Grassi G, Menato G, et al. Placental and maternal sFlt1\/PlGF expression in gestational diabetes mellitus. Sci Rep. 2021;11(2312). https:\/\/doi.org\/10.1038\/s41598-021-81785-5.","DOI":"10.1038\/s41598-021-81785-5"},{"issue":"3","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2010.04.015","volume":"89","author":"\u00d6 Karacay","year":"2010","unstructured":"Karacay \u00d6, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalva\u00e7 S, Akyol M, et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Pract. 2010;89(3):231\u20138. https:\/\/doi.org\/10.1016\/j.diabres.2010.04.015.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00404-014-3220-x","volume":"290","author":"MFB De Resende Guimar\u00e3es","year":"2014","unstructured":"De Resende Guimar\u00e3es MFB, Brand\u00e3o AHF, De Lima Rezende CA, Cabral ACV, Brum AP, Leite HV, et al. Assessment of endothelial function in pregnant women with preeclampsia and gestational diabetes mellitus by flow-mediated dilation of brachial artery. Arch Gynecol Obstet. 2014;290(3):441\u20137. https:\/\/doi.org\/10.1007\/s00404-014-3220-x.","journal-title":"Arch Gynecol Obstet"},{"key":"1050_CR22","volume-title":"Hypertension in pregnancy: the management ofHypertensive disorders during pregnancy","author":"National Institute for Health and Care Excellence (NICE)","year":"2010","unstructured":"National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: the management ofHypertensive disorders during pregnancy. London: RCOG Press; 2010."},{"issue":"12","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","volume":"28","author":"National Diabetes Data Group","year":"1979","unstructured":"National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28(12):1039\u201357.","journal-title":"Diabetes"},{"issue":"2","key":"1050_CR24","first-page":"121","volume":"93","author":"L Leeman","year":"2016","unstructured":"Leeman L, Dresang LT, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2016;93(2):121\u20137.","journal-title":"Am Fam Physician"},{"key":"1050_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"10","author":"C Athukorala","year":"2010","unstructured":"Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth. 2010;10:1\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(10)60279-6.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9741","key":"1050_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EAP Steegers","year":"2010","unstructured":"Steegers EAP, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631\u201344.","journal-title":"Lancet"},{"issue":"2","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.siny.2009.09.002","volume":"15","author":"T Sathyapalan","year":"2010","unstructured":"Sathyapalan T, Mellor D, Atkin SL. Obesity and gestational diabetes. Semin Fetal Neonatal Med. 2010;15(2):89\u201393. https:\/\/doi.org\/10.1016\/j.siny.2009.09.002.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"636","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.00636","volume":"11","author":"G Li","year":"2020","unstructured":"Li G, Wei T, Ni W, Zhang A, Zhang J, Xing Y, et al. Incidence and risk factors of gestational diabetes mellitus: a prospective cohort study in Qingdao, China. Front Endocrinol. 2020;11(636):1\u20139. https:\/\/doi.org\/10.3389\/fendo.2020.00636.","journal-title":"Front Endocrinol"},{"issue":"2","key":"1050_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5694\/j.1326-5377.2006.tb00115.x","volume":"184","author":"LK Callaway","year":"2006","unstructured":"Callaway LK, Prins JB, Chang AM, Mcintyre HD. Australian obstetric population. Med J Aust. 2006;184(2):56\u20139.","journal-title":"Med J Aust"},{"issue":"1","key":"1050_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/AOG.0000000000003901","volume":"136","author":"MJ Bicocca","year":"2020","unstructured":"Bicocca MJ, Mendez-Figueroa H, Chauhan SP, Sibai BM. Maternal obesity and the risk of early-onset and late-onset hypertensive disorders of pregnancy. Obstet Gynecol. 2020;136(1):118\u201327. https:\/\/doi.org\/10.1097\/AOG.0000000000003901.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"1050_CR31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/1471-0528.15661","volume":"126","author":"S Santos","year":"2019","unstructured":"Santos S, Voerman E, Amiano P, Barros H, Beilin LJ, Bergstr\u00f6m A, et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, north American and Australian cohorts. BJOG Int J Obs Gy. 2019;126(8):984\u201395.","journal-title":"BJOG Int J Obs Gy"},{"issue":"4","key":"1050_CR32","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184\u2013223. https:\/\/doi.org\/10.3390\/ijms15046184.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/aje\/kwi334","volume":"162","author":"LM Bodnar","year":"2005","unstructured":"Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol. 2005;162(12):1198\u2013206. https:\/\/doi.org\/10.1093\/aje\/kwi334.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1050_CR34","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1210\/jc.2003-030241","volume":"88","author":"EW Seely","year":"2003","unstructured":"Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88(6):2393\u20138. https:\/\/doi.org\/10.1210\/jc.2003-030241.","journal-title":"J Clin Endocrinol Metab"},{"key":"1050_CR35","doi-asserted-by":"publisher","first-page":"e000101","DOI":"10.1136\/bmjopen-2011-000101","volume":"1","author":"CL Roberts","year":"2014","unstructured":"Roberts CL, Ford JB, Algert CS, Antonsen S, Chalmers J, Cnattingius S, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open. 2014;1:e000101. https:\/\/doi.org\/10.1136\/bmjopen-2011-000101.","journal-title":"BMJ Open"},{"issue":"4","key":"1050_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1751-7176.2011.00440.x","volume":"13","author":"SD Sullivan","year":"2011","unstructured":"Sullivan SD, Umans JG, Ratner R. Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies. J Clin Hypertens. 2011;13(4):275\u201384. https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00440.x.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"1050_CR37","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.ajog.2004.03.074","volume":"191","author":"Y Yogev","year":"2004","unstructured":"Yogev Y, Xenakis EMJ, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol. 2004;191(5):1655\u201360. https:\/\/doi.org\/10.1016\/j.ajog.2004.03.074.","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"1050_CR38","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr UH. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991\u20132002.","journal-title":"N Engl J Med"},{"issue":"3 SUPPL","key":"1050_CR39","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ajog.2005.06.041","volume":"193","author":"I Hendler","year":"2005","unstructured":"Hendler I, Blackwell SC, Mehta SH, Whitty JE, Russell E, Sorokin Y, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol. 2005;193(3 SUPPL):979\u201383. https:\/\/doi.org\/10.1016\/j.ajog.2005.06.041.","journal-title":"Am J Obstet Gynecol"},{"key":"1050_CR40","doi-asserted-by":"publisher","unstructured":"G\u00f6z\u00fck\u00fc\u00e7\u00fck M, G\u00fcrsoy AY, Desteg\u00fcl E, Ta\u015fkin S, \u015eat\u0131ro\u011flu H. Adiponectin and leptin levels in normal weight women with polycystic ovary syndrome. Horm Mol Biol Clin Invest. 2020;41(4). https:\/\/doi.org\/10.4103\/GMIT.GMIT_30_20.","DOI":"10.4103\/GMIT.GMIT_30_20"},{"key":"1050_CR41","doi-asserted-by":"publisher","unstructured":"Xiao W, He J, Shen S, Lu J, Kuang Y, Wei X, et al. Maternal circulating leptin profile during pregnancy and gestational diabetes mellitus. Diabetes Res Clin Pract. 2020:108041. https:\/\/doi.org\/10.1016\/j.diabres.2020.108041.","DOI":"10.1016\/j.diabres.2020.108041"},{"issue":"1","key":"1050_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0301-2115(00)00401-2","volume":"96","author":"N Vitoratos","year":"2001","unstructured":"Vitoratos N, Chrystodoulacos G, Kouskouni E, Salamalekis E, Creatsas G. Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy. Eur J Obstet Gynecol Reprod Biol. 2001;96(1):59\u201362. https:\/\/doi.org\/10.1016\/S0301-2115(00)00401-2.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"1050_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.hipert.2021.11.003","volume":"39","author":"A Cortez","year":"2022","unstructured":"Cortez A, Muxfeldt E. Monocyte chemoattractant protein-1 and hypertension: an overview. Hipertens Riesgo Vasc. 2022;39(1):14\u201323. https:\/\/doi.org\/10.1016\/j.hipert.2021.11.003.","journal-title":"Hipertens Riesgo Vasc"},{"issue":"7","key":"1050_CR44","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/01.hjh.0000234111.31239.c3","volume":"24","author":"M Tucci","year":"2006","unstructured":"Tucci M, Quatraro C, Frassanito MA, Silvestris F. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia. J Hypertens. 2006;24(7):1307\u201318. https:\/\/doi.org\/10.1097\/01.hjh.0000234111.31239.c3.","journal-title":"J Hypertens"},{"issue":"14","key":"1050_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000015080","volume":"98","author":"Y Ma","year":"2019","unstructured":"Ma Y, Ye Y, Zhang J, Ruan CC, Gao PJ. Immune imbalance is associated with the development of preeclampsia. Medicine. 2019;98(14):1\u20136. https:\/\/doi.org\/10.1097\/MD.0000000000015080.","journal-title":"Medicine"},{"issue":"1","key":"1050_CR46","doi-asserted-by":"publisher","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","volume":"206","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206(1):58.e1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2011.07.037.","journal-title":"Am J Obstet Gynecol"},{"issue":"80","key":"1050_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12884-020-2744-2","volume":"20","author":"P Nikuei","year":"2020","unstructured":"Nikuei P, Rajaei M, Roozbeh N, Mohseni F, Poordarvishi F, Azad M, et al. Diagnostic accuracy of sFlt1\/PlGF ratio as a marker for preeclampsia. BMC Pregnancy Childbirth. 2020;20(80):4\u20139. https:\/\/doi.org\/10.1186\/s12884-020-2744-2.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1050_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.preghy.2018.06.017","volume":"13","author":"I Herraiz","year":"2018","unstructured":"Herraiz I, Sim\u00f3n E, G\u00f3mez-Arriaga P, Quezada M, Garc\u00eda-Burguillo A, L\u00f3pez-Jim\u00e9nez E, et al. Clinical implementation of the sFlt-1 \/ PlGF ratio to identify preeclampsia and fetal growth restriction: a prospective cohort study. Pregnancy Hypertens. 2018;13:279\u201385. https:\/\/doi.org\/10.1016\/j.preghy.2018.06.017.","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"1050_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/10641955.2013.837175","volume":"33","author":"AL Cohen","year":"2014","unstructured":"Cohen AL, Wenger JB, James-Todd T, Lamparello BM, Halprin E, Serdy S, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014;33(1):81\u201392. https:\/\/doi.org\/10.3109\/10641955.2013.837175.","journal-title":"Hypertens Pregnancy"},{"key":"1050_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00125-008-1182-x","volume":"52","author":"Y Yu","year":"2009","unstructured":"Yu Y, Jenkins AJ, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, et al. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia. 2009;52:160\u20138. https:\/\/doi.org\/10.1007\/s00125-008-1182-x.","journal-title":"Diabetologia"},{"key":"1050_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.preghy.2018.09.003","volume":"14","author":"R Minhas","year":"2018","unstructured":"Minhas R, Young D, Naseem R, Mueller A, Chinthala S, Lopes J, et al. Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension. Pregnancy Hypertens. 2018;14:110\u20134. https:\/\/doi.org\/10.1016\/j.preghy.2018.09.003.","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"1050_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejogrb.2004.11.015","volume":"122","author":"AC Staff","year":"2005","unstructured":"Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;122(1):33\u20139. https:\/\/doi.org\/10.1016\/j.ejogrb.2004.11.015.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"1050_CR53","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/hr.2010.92","volume":"33","author":"A Molvarec","year":"2010","unstructured":"Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rig\u00f3 J. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res. 2010;33(9):892\u20138. https:\/\/doi.org\/10.1038\/hr.2010.92.","journal-title":"Hypertens Res"},{"issue":"2","key":"1050_CR54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","volume":"71","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Cerdeira AS, Redman C, Vatish M. Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study. Hypertension. 2018;71(2):306\u201316. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10182.","journal-title":"Hypertension"},{"issue":"202","key":"1050_CR55","first-page":"237","volume":"135","author":"ACOG","year":"2020","unstructured":"ACOG. Clinical management guidelines for obstetrician \u2013 gynecologists gestational hypertension and. Obstet Gynecol. 2020;135(202):237\u201360.","journal-title":"Obstet Gynecol"},{"key":"1050_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cca.2022.01.021","volume":"528","author":"H Yang","year":"2022","unstructured":"Yang H, Guo F, Guo Q, Wang Y, He P, Zhang H. Clinica Chimica Acta the clinical value of PlGF and the sFlt1 \/ PlGF ratio in the management of hypertensive pregnancy disorders: a retrospective real-world study in China. Clin Chim Acta. 2022;528:90\u20137. https:\/\/doi.org\/10.1016\/j.cca.2022.01.021.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1050_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/10641955.2013.827205","volume":"32","author":"T Engels","year":"2013","unstructured":"Engels T, Pape J, Schoofs K, Henrich W, Verlohren S. Automated measurement of sFlt1, PlGF and sFlt1\/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders. Hypertens Pregnancy. 2013;32(4):459\u201373. https:\/\/doi.org\/10.3109\/10641955.2013.827205.","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"1050_CR58","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3109\/07420528.2011.580871","volume":"28","author":"RC Hermida","year":"2011","unstructured":"Hermida RC, Chay\u00e1n L, Ayala DE, Moj\u00f3n A, Fontao MJ, Fern\u00e1ndez JR. Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension. Chronobiol Int. 2011;28(6):509\u201319. https:\/\/doi.org\/10.3109\/07420528.2011.580871.","journal-title":"Chronobiol Int"},{"issue":"6","key":"1050_CR59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/01.HYP.24.6.793","volume":"24","author":"P Verdecchia","year":"1994","unstructured":"Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24(6):793\u2013801. https:\/\/doi.org\/10.1161\/01.HYP.24.6.793.","journal-title":"Hypertension"},{"issue":"10","key":"1050_CR60","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3109\/07420528.2015.1113804","volume":"32","author":"RC Hermida","year":"2015","unstructured":"Hermida RC, Smolensky MH, Ayala DE, Portaluppi F. Ambulatory blood pressure monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiol Int. 2015;32(10):1329\u201342. https:\/\/doi.org\/10.3109\/07420528.2015.1113804.","journal-title":"Chronobiol Int"},{"issue":"4","key":"1050_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/ajh\/hpw209","volume":"30","author":"G Amah","year":"2017","unstructured":"Amah G, Ouardani R, Pasteur-Rousseau A, Voicu S, Safar ME, Kubis N, et al. Extreme-dipper profile, increased aortic stiffness, and impaired subendocardial viability in hypertension. Am J Hypertens. 2017;30(4):417\u201326. https:\/\/doi.org\/10.1093\/ajh\/hpw209.","journal-title":"Am J Hypertens"},{"issue":"5","key":"1050_CR62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3109\/10641963.2016.1163368","volume":"38","author":"K Nakai","year":"2016","unstructured":"Nakai K, Fujii H, Watanabe K, Watanabe S, Awata R, Kono K, et al. Riser pattern is a predictor of kidney mortality among patients with chronic kidney disease. Clin Exp Hypertens. 2016;38(5):476\u201381. https:\/\/doi.org\/10.3109\/10641963.2016.1163368.","journal-title":"Clin Exp Hypertens"},{"issue":"1\u20132","key":"1050_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/07420528.2012.701127","volume":"30","author":"RC Hermida","year":"2013","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level-the \u201cnormotensive non-dipper\u201d paradox. Chronobiol Int. 2013;30(1\u20132):87\u201398. https:\/\/doi.org\/10.3109\/07420528.2012.701127.","journal-title":"Chronobiol Int"},{"issue":"1","key":"1050_CR64","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1097\/00004872-200211000-00017","volume":"20","author":"T Ohkubo","year":"2002","unstructured":"Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the ohasama study. J Hypertens. 2002;20(1):2183\u20139. https:\/\/doi.org\/10.1097\/00004872-200211000-00017.","journal-title":"J Hypertens"},{"issue":"2","key":"1050_CR65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4321\/S2254-28842019000200006","volume":"22","author":"C Garc\u00eda-Serrano","year":"2019","unstructured":"Garc\u00eda-Serrano C, Micol-Bachiller M, Betr\u00e1n-Biurrun D, Aran-Sol\u00e9 L, Pujol-Salud J. Circadian rhytm of blood pressure and the relation to cardiovascular risk factors. Enferm Nefrol. 2019;22(2):151\u20138.","journal-title":"Enferm Nefrol"},{"issue":"6","key":"1050_CR66","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1586\/erc.10.29","volume":"8","author":"C Cuspidi","year":"2010","unstructured":"Cuspidi C, Giudici V, Negri F, Sala C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review. Expert Rev Cardiovasc Ther. 2010;8(6):781\u201392. https:\/\/doi.org\/10.1586\/erc.10.29.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1050_CR67","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2337\/diacare.22.9.1507","volume":"22","author":"L Flores","year":"1999","unstructured":"Flores L, Levy I, Aguilera E, Martinez S, Gomis R, Esmatjes E. Usefulness of ambulatory blood pressure monitoring in pregnant women with type 1 diabetes. Diabetes Care. 1999;22:1507\u201311. https:\/\/doi.org\/10.2337\/diacare.22.9.1507.","journal-title":"Diabetes Care"},{"key":"1050_CR68","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.endien.2018.07.004","volume":"65","author":"B S\u00e1nchez-Lechuga","year":"2018","unstructured":"S\u00e1nchez-Lechuga B, Lara-Barea A, C\u00f3rdoba-Do\u00f1a JA, Montero Galv\u00e1n A, Abal Cruz A, Aguilar-Diosdado M, et al. Usefulness of blood pressure monitoring in patients with gestational diabetes mellitus. Endocrinol Diabetes y Nutr. 2018;65:394\u2013401. https:\/\/doi.org\/10.1016\/j.endien.2018.07.004.","journal-title":"Endocrinol Diabetes y Nutr"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-01050-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-01050-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-01050-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T12:44:55Z","timestamp":1701607495000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-01050-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-01050-w","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Board of Puerta del Mar Hospital (1507-N-16) in C\u00e1diz, Spain. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}